What's in Apothyx, Co.'s pipeline?

Apothyx, Co. has 6 drugs in our index: 3 marketed, 0 filed, 3 in Phase 3, 0 in Phase 2, 0 in Phase 1.

Which companies overlap with Apothyx, Co.'s portfolio?

No competitive overlap detected.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/apothyx-co.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-15 · How we verify

Apothyx, Co. — Portfolio Competitive Intelligence Brief

Apothyx, Co. pipeline: 3 marketed, 0 filed, 3 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

3 marketed 0 filed 3 Phase 3 0 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area
Bengay	Bengay	marketed			Other
Icy Hot	Icy Hot	marketed	Topical counterirritant/analgesic		Pain Management
Tiger Balm	Tiger Balm	marketed	Topical counter-irritant / rubefacient	TRPM8, TRPA1 (transient receptor potential channels)	Pain Management / Musculoskeletal
Extract Labs Muscle Cream	Extract Labs Muscle Cream	phase 3			Pain Management / Musculoskeletal
GoodFOR Pain	GoodFOR Pain	phase 3			Pain Management
Essential Wholesale Muscle Gel	Essential Wholesale Muscle Gel	phase 3			Pain Management / Musculoskeletal

Therapeutic area mix

Pain Management / Musculoskeletal · 3
Pain Management · 2
Other · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

No competitive overlap data.

Subscribe to ongoing alerts

Every new pipeline event for Apothyx, Co.:

Cite this brief

Drug Landscape (2026). Apothyx, Co. — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/apothyx-co. Accessed 2026-05-15.